Beam Therapeutics
BEAM
#4112
Rank
NZ$3.74 B
Marketcap
$45.27
Share price
3.68%
Change (1 day)
20.26%
Change (1 year)

Beam Therapeutics (BEAM) - Cash on Hand

Cash on Hand as of September 2024 : NZ$1.54 Billion

According to Beam Therapeutics 's latest financial reports the company has NZ$1.54 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Beam Therapeutics - Cash on Hand chart (from 2018 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31NZ$1.88 B10.8%
2022-12-31NZ$1.69 B20.11%
2021-12-31NZ$1.41 B240.4%
2020-12-31NZ$0.41 B204.54%
2019-12-31NZ$0.13 B-37.53%
2018-12-31NZ$0.21 B8056.31%
2017-12-31NZ$2.67 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
NZ$0.47 B-69.06%๐Ÿ‡บ๐Ÿ‡ธ USA